Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Total Debt (2016 - 2026)

Conmed filings provide 17 years of Total Debt readings, the most recent being $860.9 million for Q1 2026.

  • On a quarterly basis, Total Debt fell 3.51% to $860.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $860.9 million, a 3.51% decrease, with the full-year FY2025 number at $834.9 million, down 7.82% from a year prior.
  • Total Debt hit $860.9 million in Q1 2026 for Conmed, up from $834.9 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $1.1 billion in Q1 2023 to a low of $715.8 million in Q1 2022.
  • Median Total Debt over the past 5 years was $965.9 million (2024), compared with a mean of $941.7 million.
  • Biggest five-year swings in Total Debt: surged 54.07% in 2022 and later fell 9.96% in 2025.
  • Conmed's Total Debt stood at $1.1 billion in 2022, then dropped by 7.68% to $973.8 million in 2023, then dropped by 6.99% to $905.8 million in 2024, then decreased by 7.82% to $834.9 million in 2025, then grew by 3.11% to $860.9 million in 2026.
  • The last three reported values for Total Debt were $860.9 million (Q1 2026), $834.9 million (Q4 2025), and $853.8 million (Q3 2025) per Business Quant data.